| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |